Search

Your search keyword '"Lee, Eui-Don"' showing total 28 results
Start Over Author "Lee, Eui-Don"
28 results on '"Lee, Eui-Don"'

10. Image-Guided Stereotactic Body Radiation Therapy in Patients With Isolated Para-Aortic Lymph Node Metastases From Uterine Cervical and Corpus Cancer

Author

Choi, Chul Won, primary, Cho, Chul Koo, additional, Yoo, Seong Yul, additional, Kim, Mi Sook, additional, Yang, Kwang Mo, additional, Yoo, Hyung Jun, additional, Seo, Young Seok, additional, Kang, Jin Kyu, additional, Lee, Dong Han, additional, Lee, Kyung Hee, additional, Lee, Eui Don, additional, Rhu, Sang Young, additional, Choi, Suck Chul, additional, Kim, Moon Hong, additional, and Kim, Beob Jong, additional

Published
2009
Full Text
View/download PDF

11. Accelerated Hyperfractionated Radiotherapy for Locally Advanced Uterine Cervix Cancers

Author

Seo, Young Seok, primary, Cho, Chul Koo, additional, Yoo, Seong Yul, additional, Kim, Mi Sook, additional, Yang, Kang Mo, additional, Yoo, Hyung Jun, additional, Choi, Chul Won, additional, Lee, Kyung Hee, additional, Lee, Eui Don, additional, Rhu, Sang Young, additional, Choi, Suck Chul, additional, Kim, Moon Hong, additional, and Kim, Beob Jong, additional

Published
2008
Full Text
View/download PDF

28. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.

Author

Lee WM, Park SI, Kim BJ, Kim MH, Choi SC, Lee ED, and Ryu SY

Subjects
Adenocarcinoma pathology, Adenocarcinoma radiotherapy, Adenocarcinoma therapy, Adult, Aged, Aged, 80 and over, Antineoplastic Agents therapeutic use, Carcinoma radiotherapy, Carcinoma, Adenosquamous pathology, Carcinoma, Adenosquamous radiotherapy, Carcinoma, Adenosquamous therapy, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell therapy, Cisplatin therapeutic use, Confidence Intervals, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Multivariate Analysis, Neoplasm Metastasis, Neoplasm Staging, Odds Ratio, Proportional Hazards Models, Retrospective Studies, Tumor Burden, Uterine Cervical Neoplasms radiotherapy, Carcinoma pathology, Carcinoma therapy, Chemoradiotherapy, Hysterectomy, Neoplasm Recurrence, Local pathology, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms therapy
Abstract

Objective: Locally advanced bulky cervical cancer (LABCC) is characterized by poor local control. The objective of this study was to identify the clinicopathologic variables associated with one-year central-only recurrence, which will serve as criteria for adjuvant hysterectomy after radiation (AHR) in patients with LABCC., Study Design: Between January 2000 and August 2007, we retrospectively evaluated outcomes in 225 patients with LABCC who were initially treated with radiation or chemoradiation., Results: Among the 225 patients with LABCC, there were 41 recurrences within one year after treatment (8 central-only and 33 pelvis and/or distant site recurrences). Age, stage, and treatment type were not associated with the one-year central-only recurrences, but tumor size ≥8cm had a statistically significant association based on multivariate analysis (OR, 5.39; 95% CI, 1.15-25.31; p=0.03). The combination of non-squamous cell (non-SCC) type and tumor size ≥8cm had a significantly higher rate of recurrence within one year (OR, 43.0; 95% CI, 4.78-386.68; p<0.01)., Conclusions: Of patients with LABCC, those with non-SCC tumors ≥8cm in size were at high risk for early central-only recurrence after cisplatin-based chemoradiation, and represent the subset of patients for whom AHR is beneficial., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results